<!DOCTYPE html>
<html lang="en"><head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<link href="https://cdn-icons-png.flaticon.com/512/4021/4021693.png" rel="icon"/>
<link href="../style.css" rel="stylesheet"/>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600&amp;family=Space+Mono:wght@400;700&amp;display=swap" rel="stylesheet"/>
<title>Meclofenoxate</title>
</head><body><main class="container"><header class="site-header">
<h1 class="logo"><a href="../index.html">r/anhedonia</a></h1>
<p class="subtitle">Personal Wiki</p>
</header><nav style="margin-bottom: 20px;"><a href="../actions.html">← Back to Personal Wiki</a></nav><section class="card"><h2>Meclofenoxate</h2><ul>
<li><img src="https://upload.wikimedia.org/wikipedia/commons/thumb/c/c8/Meclofenoxate.svg/250px-Meclofenoxate.svg.png"/></li>
<li>Pharmacological Actions</li>
<ul>
<li>Meclofenoxate's pharmacological actions are centered around its nootropic and neuroprotective properties. Research suggests it acts as a cholinergic agent, improving performance on memory tests, especially in elderly patients, as noted in Wikipedia: Meclofenoxate. It is believed to increase cellular membrane phospholipids, which may support neuronal membrane integrity and function, potentially contributing to cognitive enhancement. Additionally, studies indicate it may reduce lipofuscin accumulation, a cellular waste product associated with aging, suggesting anti-aging benefits (<a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/meclofenoxate">source</a>). However, the exact mechanisms and time course of these effects are not fully detailed in the literature, and further research is needed to quantify how each action influences over time.</li>
</ul>
<li>Half-life</li>
<ul>
<li>The half-life of Meclofenoxate is estimated at approximately 6 hours, derived from a pharmacokinetic study comparing capsule and tablet formulations in healthy Chinese male volunteers. The study measured the elimination half-time (T1/2) of its active metabolite, chlorophenoxyacetic acid, at 5.8 to 6.0 hours (<a href="https://www.researchgate.net/publication/23304765_Bioequivalence_and_Pharmacokinetic_Comparison_of_a_Single_200-mg_Dose_of_Meclofenoxate_Hydrochloride_Capsule_and_Tablet_Formulations_in_Healthy_Chinese_Adult_Male_Volunteers_A_Randomized_Sequence_Open">source</a>). This indicates that the drug's effects may persist for several hours after administration, but specific onset, peak, and duration data for pharmacological actions are not readily available.</li>
</ul>
<li>Bioavailability</li>
<ul>
<li>Meclofenoxate is administered via oral and parenteral routes, with both shown to be effective. It is a prodrug, rapidly hydrolyzed into DMAE and pCPA, which likely influences its bioavailability. Specific bioavailability percentages, particularly for the oral route, are not widely documented. However, a study on bioequivalence suggests that both capsule and tablet formulations are similarly absorbed, with 90% confidence intervals for Cmax and AUC within the FDA's 80%-125% range, indicating comparable bioavailability (<a href="https://nootropicsexpert.com/centrophenoxine/">source</a>).</li>
</ul>
<li>Dosages</li>
<ul>
<li>Dosage recommendations vary based on the condition and administration route. Typical daily dosages range from 500 mg to 1,000 mg, as suggested by Nootropics Expert: Centrophenoxine, with higher doses up to 2,000 mg daily used in clinical trials for age-related cognitive disorders like Alzheimer's disease, as noted by the Alzheimer's Drug Discovery Foundation (<a href="https://www.mims.com/philippines/drug/info/meclofenoxate?mtype=generic">source</a>). This suggests a safe range of 500 mg to 2,000 mg daily, with the minimum effective dose likely around 500 mg daily based on typical use, and the maximum safe dose potentially up to 2,000 mg, though safety concerns increase at higher levels.</li>
</ul>
<li>Safety and Side Effects</li>
<ul>
<li>Meclofenoxate is considered safe with high tolerability, as noted in Wikipedia: Meclofenoxate, with possible side effects including insomnia, dizziness, restlessness, muscle tremor, depression, nausea, muscle tension, and headache, which may indicate overdosage. The Alzheimer's Drug Discovery Foundation highlights that most side effects are mild, such as gastrointestinal issues and mild stimulant effects, but raises concerns about DMAE, with serious adverse events reported in a trial, including cardiac failure leading to death, cardiac arrest, and seizures (<a href="https://www.alzdiscovery.org/cognitive-vitality/ratings/centrophenoxine">source</a>). Preclinical studies also link DMAE to neural tube defects, advising against use in women of child-bearing age, and it is contraindicated in individuals with severely high blood pressure. Drug interactions are unknown, and consultation with a healthcare provider is recommended before use.</li>
</ul>
</ul></section><footer class="site-footer">
<p><a href="../index.html">← Back to Home</a></p>
</footer></main><script src="../js/router.js"></script></body></html>